Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy
1997
Role of Platelet-Derived Endothelial Cell Growth Factor in Tumor Growth and Therapy Response
publication
Evidence: moderate
Author Information
Author(s): L Griffiths, IJ Strafford
Primary Institution: University of Manchester
Hypothesis
How does platelet-derived endothelial cell growth factor (PD-ECGF) influence tumor growth and response to therapy?
Conclusion
PD-ECGF is critical for angiogenesis and tumor growth, and its activity may influence the effectiveness of chemotherapy.
Supporting Evidence
- PD-ECGF is highly expressed in tumors compared to normal tissues.
- Elevated PD-ECGF levels correlate with tumor growth and metastasis.
- PD-ECGF's enzymatic activity is essential for its angiogenic properties.
- PD-ECGF may enhance the effectiveness of chemotherapy agents like 5-fluorouracil.
Takeaway
PD-ECGF helps tumors grow by making new blood vessels, and it can also affect how well some cancer treatments work.
Methodology
This review summarizes recent findings on PD-ECGF's role in tumor biology and its enzymatic activity related to angiogenesis.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Want to read the original?
Access the complete publication on the publisher's website